Anti-CD7 CAR T-cell therapy

DB18128ExperimentalCell transplant therapies

Anti-CD7 CAR T-cell therapy: Overview.

Also known as
A chimeric antigen receptor (CAR) immunotherapy directed against the target protein CD7

Which companies are running trials of Anti-CD7 CAR T-cell therapy, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In